Further, we found that NKp30 is expressed in significantly lower levels among NK cells of metastatic melanoma patients as compared to healthy donors (Figure 6), and consequently that blocking of NKp30 did not alter the anti melanoma function of these NK cells (Figure 9E). The gene discussed is NCR3; the disease is metastatic melanoma.